CMND and PLRZ Related Headlines
Go Back- LDB Capital Corp. Announces Definitive Agreement for Proposed Qualifying Transaction with Eventer Technologies Ltd.
- Taurus Gold Corp. Management Updates
- Clearmind Medicine partners with Polyrizon for intranasal MEAI formulation
- Polyrizon partners with Clearmind to develop intranasal MEAI formulation
- Clearmind Medicine Enters into Development Agreement to Advance Intranasal Formulation for its Proprietary Non-Hallucinogenic Neuroplastogen MEAI
- Polyrizon Signs an Agreement to Develop Intranasal Proprietary Non-Hallucinogenic Neuroplastogen Formulation
CMND and PLRZ Related Press Releases
Go Back- LDB Capital Corp. Announces Definitive Agreement for Proposed Qualifying Transaction with Eventer Technologies Ltd.
- Taurus Gold Corp. Management Updates
- Clearmind Medicine Enters into Development Agreement to Advance Intranasal Formulation for its Proprietary Non-Hallucinogenic Neuroplastogen MEAI
- Polyrizon Signs an Agreement to Develop Intranasal Proprietary Non-Hallucinogenic Neuroplastogen Formulation
